Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel Free KLRS Stock Alerts

Kalaris Therapeutics (KLRS) Institutional Ownership

Kalaris Therapeutics logo
$4.75 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$4.81 +0.06 (+1.26%)
As of 07/2/2026 04:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Kalaris Therapeutics (NASDAQ:KLRS)

Current
Institutional Ownership
Percentage
66.05%
Number of
Institutional Buyers
(last 12 months)
29
Total
Institutional Inflows
(last 12 months)
$33.38M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$2.17M
Get KLRS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kalaris Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

KLRS Institutional Buying and Selling by Quarter

Kalaris Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2026Kalehua Capital Management LLC135,585$782K0.6%-3.1%0.570%
5/14/2026Renaissance Technologies LLC66,151$382K0.0%-24.6%0.288%
5/7/2026WealthTrust Asset Management LLC12,416$72K0.0%N/A0.054%
4/27/2026Simplify Asset Management Inc.87,426$504K0.0%+335.5%0.381%
2/18/2026XTX Topco Ltd10,897$92K0.0%N/A0.058%
2/18/2026Ikarian Capital LLC360,000$3.04M0.2%N/A1.925%
2/18/2026RTW Investments LP1,300,000$10.97M0.1%N/A6.952%
2/18/2026Boothbay Fund Management LLC92,261$779K0.0%N/A0.493%
2/18/2026683 Capital Management LLC80,590$680K0.0%N/A0.431%
2/17/2026ADAR1 Capital Management LLC100,000$844K0.1%N/A0.535%
2/17/2026Paradigm Biocapital Advisors LP700,000$5.91M0.2%N/A3.743%
2/16/2026Squarepoint Ops LLC25,367$214K0.0%-36.9%0.136%
2/16/2026OMERS ADMINISTRATION Corp30,000$253K0.0%N/A0.160%
2/16/2026Barclays PLC6,065$51K0.0%N/A0.032%
2/13/2026Marshall Wace LLP72,876$615K0.0%+416.3%0.390%
2/13/2026Walleye Capital LLC11,225$95K0.0%N/A0.060%
2/13/2026Kalehua Capital Management LLC139,901$1.18M1.1%N/A0.748%
2/13/2026Alyeska Investment Group L.P.403,551$3.40M0.0%N/A2.158%
2/13/2026Siren L.L.C.435,798$3.68M0.1%+36.9%2.330%
2/13/2026State Street Corp25,410$214K0.0%+12.4%0.136%
2/12/2026Jane Street Group LLC33,114$279K0.0%N/A0.177%
2/12/2026Renaissance Technologies LLC87,751$741K0.0%-22.2%0.469%
2/12/2026Keel Point LLC10,225$86K0.0%N/A0.055%
2/11/2026Propel Bio Management LLC42,053$355K0.3%N/A0.225%
2/10/2026Goldman Sachs Group Inc.34,303$290K0.0%+52.7%0.183%
2/9/2026Geode Capital Management LLC82,647$698K0.0%+28.0%0.442%
2/9/2026Simplify Asset Management Inc.20,074$169K0.0%N/A0.107%
2/6/2026Nano Cap New Millennium Growth Fund L P4,000$34K0.0%N/A0.021%
2/5/2026WHI TRUST Co LLC97,493$823K0.6%N/A0.521%
11/17/2025Woodline Partners LP241,102$1.39M0.0%N/A1.289%
11/17/2025Millennium Management LLC24,923$144K0.0%-53.9%0.133%
11/14/2025Bridgeway Capital Management LLC22,500$130K0.0%N/A0.120%
11/14/2025Squarepoint Ops LLC40,173$232K0.0%-32.0%0.215%
11/13/2025Johnson Financial Group Inc.10,000$58K0.0%N/A0.053%
11/3/2025Belpointe Asset Management LLC40,000$231K0.0%N/A0.214%
10/31/2025Fortis Capital Advisors LLC40,000$231K0.0%N/A0.214%
8/15/2025Octagon Capital Advisors LP360,000$961K0.2%-25.2%1.925%
8/14/2025Gilead Sciences Inc.317,789$848K0.1%-56.1%1.699%
8/12/2025XTX Topco Ltd24,234$65K0.0%N/A0.130%


KLRS Institutional Ownership - Frequently Asked Questions

During the previous two years, 34 institutional investors and hedge funds held shares of Kalaris Therapeutics. The most heavily invested institutionals were RTW Investments LP ($10.97M), Paradigm Biocapital Advisors LP ($5.91M), Siren L.L.C. ($3.68M), Alyeska Investment Group L.P. ($3.40M), Ikarian Capital LLC ($3.04M), Woodline Partners LP ($1.39M), and Octagon Capital Advisors LP ($961K).Learn more on Kalaris Therapeutics' institutional investors.

66.05% of Kalaris Therapeutics' stock is owned by institutional investors. Learn more on KLRS's institutional investor holdings.

Of the 29 institutional investors that purchased Kalaris Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($1.30M), Paradigm Biocapital Advisors LP ($700K), Alyeska Investment Group L.P. ($403.55K), Ikarian Capital LLC ($360K), Woodline Partners LP ($241.10K), Kalehua Capital Management LLC ($139.90K), and Siren L.L.C. ($117.53K).

Institutional investors have bought a total of 4,108,082 shares in the last 24 months. This purchase volume represents approximately $33.38M in transactions.

The following institutional investors have sold Kalaris Therapeutics stock in the last 24 months: Gilead Sciences Inc. ($405.48K), Octagon Capital Advisors LP ($121K), Renaissance Technologies LLC ($46.60K), Squarepoint Ops LLC ($33.73K), Millennium Management LLC ($29.17K), and Kalehua Capital Management LLC ($4.32K).

Institutional investors have sold a total of 640,297 shares in the last 24 months. This volume of shares sold represents approximately $2.17M in transactions.


Related Companies

This page (NASDAQ:KLRS) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel